SHILPA MEDICARE LTD. - Shilpa Pharma Lifesciences Limited, Unit 2, Raichur, Karnataka Has Cleared The COFEPRIS-Mexico GMP Inspection

Download	< Back
23 Jul 2024
Shilpa Medicare Limited''s 100% subsidiary, Shilpa Pharma Lifesciences Limited Active Pharmaceutical Ingredient (API) manufacturing facility, Unit II situated at Raichur in Karnataka state has undergone a GMP inspection by COFEPRIS - Mexico from November 6-10, 2023
View all announcements for SHILPA MEDICARE LTD.	Source: BSE India

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us